Yes but only applies to CEs with no in-house pharmacy. Only one CP designation is allowed and the CP needs to be within 40 miles of the parent site. Such CEs can also designate a second CP for AbbVie’s 2 LDDs (Duopa and Imbruvica).
No CP access for CEs with in-house pharmacy.
Yes but only one CP designation is allowed and the CP needs to be within 40 miles of the parent site. Such CEs can also designate a second CP for AbbVie’s 2 LDDs (Duopa and Imbruvica).
CREON®, DEPAKOTE®, DUOPA®, GENGRAF®, HUMIRA®, IMBRUVICA®, KALETRA®, K-TAB®, LUPRON®, MAVYRET®, NIASPAN®, NIMBEX®, NORVIR®, ORIAHNN®, ORILISSA®, RINVOQ®, SKYRIZI®, SURVANTA®, SYNTHROID®, TRICOR®, TRILIPIX®, ULTANE®, VIEKIRA PAK®, ZEMPLAR®, ACTONEL®, ACULAR®, ACULAR® LS, ACUVAIL®, ALOCRIL®, ALPHAGAN® P, ANDRODERM®, ARMOUR® THYROID, ASACOL® HD, ATELVIA®, AVYCAZ®, BENTYL®, BOTOX®, BYSTOLIC®, CANASA®, CARAFATE®, CELEXA®, COMBIGAN®, CONDYLOX®, CRINONE®, DALVANCE®, DELZICOL®, DURYSTA®, ESTRACE®, FETZIMA®, FML®, FML FORTE®, GELNIQUE®, GENERESS® FE, INFED®, KADIAN®, KYBELLA®, LASTACAFT®, LATISSE®, LEXAPRO®, LINZESS®, LO LOESTRIN® FE, LUMIGAN®, MINASTRIN® 24 Fe, MONUROL®, NAMENDA® / NAMENDA XR®, NAMZARIC®, OCUFLOX®, OXYTROL®, OZURDEX®, POLYTRIM®, PRED FORTE®, PRED MILD®, PYLERA®, QULIPTA®, RAPAFLO®, RECTIV®, REFRESH®, RESTASIS®, SAPHRIS®, SAVELLA®, TAYTULLA®, TEFLARO®, UBRELVY®, URSO FORTE® / URSO 250®, VANIQA®, VIBERZI®, VIIBRYD®, VRAYLAR®, VUITY™, ZYMAXID®”
Policy applies to hospitals covered entities only. Federal grantees are exempted from this policy.
Q: If I designate one contract pharmacy location to receive orders of medicines subject to this policy, should I also make a separate designation for a contract pharmacy location to receive AbbVie medicines subject to a limited distribution network?
Yes, you should separately designate one contract pharmacy location to receive medicines subject to a limited distribution network. AbbVie will facilitate bill to/ ship to orders to this designated pharmacy. Currently, this separate contract pharmacy designation is available for Duopa and Imbruvica. Accordingly, this pharmacy designation may be in addition to the one permitted contract pharmacy designation for other AbbVie medicines. Please access 340B ESP™ at www.340BESP.com to make this selection.